Immunic | VTL - Pre Tax Profit


Immunic reported $-19.3M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
BioMarin Pharmaceutical USD 141.2M 168.36M Mar/2026
Cipla INR 7.49B 4.2B Mar/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Enanta Pharmaceuticals USD -22.71M 95.08M Dec/2024
Grifols EUR 257.85M 190.87M Dec/2024
Immunic USD -19.3M 6.28M Dec/2025
Insmed USD -162.1M 164.84M Mar/2026
Omeros USD -65.12M 21.27M Jun/2024
OraSure Technologies USD -18.43M 5.14M Dec/2025
Quidel USD -79.5M 32.9M Mar/2026
Ultragenyx Pharmaceutical USD -184M 56M Mar/2026
United Therapeutics USD 444M 6M Dec/2025
Xoma USD 15.98M 24.58M Jun/2024